IQVNYSE

IQVIA Holdings Inc.

Healthcare·Infectious Disease·Commercial·Durham, NC, United States
Infectious Disease

IQVIA Holdings Inc. (IQV): 1 pipeline candidate · 1 upcoming catalyst · ~20 mo cash runway. Updated within the last hour.

5.1/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway5.5

19.9 months

Financial Health4.8

D/E 3.75 · 2% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth3.3

1 candidate

Catalyst Momentum2.0

1 upcoming, next in ~5822d

Insider SignalN/A

N/A

A transparent, data-derived signal for IQVIA Holdings Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$29.8B

Cash

$1.9B

Quarterly Burn

$502.0M

Runway

19.9 mo

Revenue

$4.2B

Cash Runway vs Catalysts

A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.

Cash ends ~Feb 2028
Today~210 mo out
Catalyst within runwayCatalyst after cash runs out

Pipeline (1 candidate)

DrugPhase
taliciaApproved

Upcoming Catalysts (1)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

1,065

Total value held

$25.07B

HolderSharesValue
vanguard capital management llc22,053,966$3.76B
blackrock, inc.15,027,444$2.56B
harris associates l p12,183,275$2.08B
vanguard portfolio management llc7,576,001$1.29B
state street corp7,476,962$1.28B
geode capital management, llc4,463,052$758.2M
alliancebernstein l.p.2,878,897$648.9M
morgan stanley2,609,867$445.1M
canada pension plan investment board1,999,089$340.9M
longview partners (guernsey) ltd1,897,474$323.6M

Showing top 10 of 1,065 institutional holders of IQVIA Holdings Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Ari Bousbib

Frequently asked questions

How many drug candidates are in IQVIA Holdings Inc.'s pipeline?

IQVIA Holdings Inc. (IQV) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.

What is IQVIA Holdings Inc.'s lead drug candidate?

IQVIA Holdings Inc.'s most advanced tracked candidate is talicia (Approved).

What is IQVIA Holdings Inc.'s next catalyst?

IQVIA Holdings Inc.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: TALICIA" — expected May 27, 2042.

What is IQVIA Holdings Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, IQVIA Holdings Inc. has approximately 19.9 months of cash runway.

What is IQVIA Holdings Inc.'s market capitalization?

IQVIA Holdings Inc.'s market capitalization is approximately $29.8B.

Get the full picture on IQVIA Holdings Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.